These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9797864

  • 1. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model.
    Li Z, Rakkar A, Katayose Y, Kim M, Shanmugam N, Srivastava S, Moul JW, McLeod DG, Cowan KH, Seth P.
    Gene Ther; 1998 May; 5(5):605-13. PubMed ID: 9797864
    [Abstract] [Full Text] [Related]

  • 2. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K, Cowan KH, Sinha BK.
    Oncol Res; 1999 May; 11(3):153-9. PubMed ID: 10527075
    [Abstract] [Full Text] [Related]

  • 3. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R, Phillips E, Hooper R, Wilson D, Partridge M.
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):943-8. PubMed ID: 15329284
    [Abstract] [Full Text] [Related]

  • 10. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.
    Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW, Cowan KH, Seth P.
    Urology; 1995 Dec 02; 46(6):843-8. PubMed ID: 7502427
    [Abstract] [Full Text] [Related]

  • 11. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
    Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM, Amin KM.
    Cancer Gene Ther; 1999 Dec 02; 6(4):291-301. PubMed ID: 10419047
    [Abstract] [Full Text] [Related]

  • 12. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
    Seth P, Katayose D, Li Z, Kim M, Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P, Cowan K.
    Cancer Gene Ther; 1997 Dec 02; 4(6):383-90. PubMed ID: 9408609
    [Abstract] [Full Text] [Related]

  • 13. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM, Wiehle SA, Koch PE, Branch C, Yen N, Roth JA, Cristiano RJ.
    Cancer Gene Ther; 1997 Dec 02; 4(3):191-8. PubMed ID: 9171938
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096
    [Abstract] [Full Text] [Related]

  • 15. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 16. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 17. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 01; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP, Sutjipto S, Wills KN, Hancock W, Cornell D, Johnson DE, Gregory RJ, Shepard HM, Maneval DC.
    Cancer Gene Ther; 1996 Nov 01; 3(2):121-30. PubMed ID: 8729911
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines].
    Guo Y, Zeng Y, Wang K, Zhu X, Luo H, Zheng M, Li M, Chen J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul 01; 9 Suppl():43-5. PubMed ID: 11509137
    [Abstract] [Full Text] [Related]

  • 20. Role of wild-type p53 in the enhancement of camptothecin cytotoxicity against human prostate tumor cells.
    Arah IN, Song K, Seth P, Cowan KH, Sinha BK.
    Anticancer Res; 1998 Jul 01; 18(3A):1845-9. PubMed ID: 9673414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.